| Literature DB >> 26455459 |
Rosario Moratalla1, Amit Khairnar2, Nicola Simola3, Noelia Granado4, Jose Ruben García-Montes4, Pier Francesca Porceddu3, Yousef Tizabi5, Giulia Costa3, Micaela Morelli6.
Abstract
Amphetamine-related drugs, such as 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH), are popular recreational psychostimulants. Several preclinical studies have demonstrated that, besides having the potential for abuse, amphetamine-related drugs may also elicit neurotoxic and neuroinflammatory effects. The neurotoxic potentials of MDMA and METH to dopaminergic and serotonergic neurons have been clearly demonstrated in both rodents and non-human primates. This review summarizes the species-specific cellular and molecular mechanisms involved in MDMA and METH-mediated neurotoxic and neuroinflammatory effects, along with the most important behavioral changes elicited by these substances in experimental animals and humans. Emphasis is placed on the neuropsychological and neurological consequences associated with the neuronal damage. Moreover, we point out the gap in our knowledge and the need for developing appropriate therapeutic strategies to manage the neurological problems associated with amphetamine-related drug abuse.Entities:
Keywords: 3,4-Methylenedioxymethamphetamine; Dopamine; Ecstasy; MDMA; METH; Methamphetamine; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat
Mesh:
Substances:
Year: 2015 PMID: 26455459 DOI: 10.1016/j.pneurobio.2015.09.011
Source DB: PubMed Journal: Prog Neurobiol ISSN: 0301-0082 Impact factor: 11.685